244 related articles for article (PubMed ID: 453214)
1. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
Dasta J; Mirtallo JM; Altman M
Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
[No Abstract] [Full Text] [Related]
2. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
Fontana G; Cresci F; Lo Sapio P; Panuccio P
Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
[TBL] [Abstract][Full Text] [Related]
3. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
Arbab OA; Wiggins J; Ayres JG; Stableforth DE
Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
[TBL] [Abstract][Full Text] [Related]
4. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
Harder S; Staib AH; Stauder J
Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
[No Abstract] [Full Text] [Related]
5. [Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].
Kaik G
Wien Med Wochenschr; 1984 Apr; 134(7):163-9. PubMed ID: 6741156
[TBL] [Abstract][Full Text] [Related]
6. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic obstructive pulmonary disease with two sustained-release theophylline preparations.
Giosue S; Bernocchi D; Parola D; Munno R; Mancini P
J Int Med Res; 1987; 15(6):352-60. PubMed ID: 3325318
[TBL] [Abstract][Full Text] [Related]
8. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels.
Steinijans VW; Zech K; Fischer R
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100
[TBL] [Abstract][Full Text] [Related]
9. Theophylline levels in patients receiving a controlled-release aminophylline preparation (Phyllocontin Continus tablets).
Friend JA
J Int Med Res; 1979; 7 Suppl 1():67-9. PubMed ID: 437310
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
Wiesner B; Sehrt I; Iwainsky H
Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
[TBL] [Abstract][Full Text] [Related]
11. Serum theophylline levels with oral sustained release theophylline after transfer from intravenous aminophylline in patients with chronic lung disease.
Silins RA; Butcher MA; Marlin GE
Br J Clin Pharmacol; 1984 Oct; 18(4):645-7. PubMed ID: 6487509
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
Gupta S; Raina RK; Samotra K; Gupta KL
Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
[TBL] [Abstract][Full Text] [Related]
13. Serum theophylline and ventilatory function in chronic obstructive lung disease. Comparison between two slow-release formulations of theophylline.
Tantucci C; Grassi V; Verdecchia P; Cornelli U; Sorbini CA
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):560-4. PubMed ID: 3905630
[TBL] [Abstract][Full Text] [Related]
14. Aminophylline injection and theophylline tablets: Acute response in partially reversible chronic airway obstruction.
Freitag A
Med J Aust; 1976 Apr; 1(14):478-9. PubMed ID: 933924
[TBL] [Abstract][Full Text] [Related]
15. Long-term therapy with sustained-release theophylline.
Myhre KI; Arnulf V; Walstad RA
Pharmatherapeutica; 1985; 4(2):92-7. PubMed ID: 3903782
[TBL] [Abstract][Full Text] [Related]
16. Rapid estimation of total body clearance of theophylline in patients receiving intravenous aminophylline infusion.
Lau AH; O'Connor T; Lam G; Lui CY; Al-Bazzaz FJ; Chiou WL
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):12-5. PubMed ID: 3957483
[TBL] [Abstract][Full Text] [Related]
17. [Prescription of Theostat 300 as a single evening dose].
Germouty J; Bida C; Moreau L
Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
[TBL] [Abstract][Full Text] [Related]
18. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
Ranke C; Schmidt G; Oellerich M; Sybrecht GW
Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
[No Abstract] [Full Text] [Related]
19. Clinical results obtained from a new controlled release theophylline preparation.
Nolte D
Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
[No Abstract] [Full Text] [Related]
20. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.
Dal Negro R; Turco P; Pomari C; Monici-Preti P
Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]